Desmethylsibutramine

Desmethylsibutramine.svg

Desmethylsibutramine is a chemical compound that is structurally related to sibutramine, a drug that was previously used as an appetite suppressant for the treatment of obesity. Desmethylsibutramine is one of the primary active metabolites of sibutramine, which means it is formed in the body when sibutramine is metabolized.

Chemical Structure and Properties

Desmethylsibutramine belongs to the class of compounds known as phenethylamines. Its chemical structure is similar to that of sibutramine, with the primary difference being the absence of a methyl group. This structural modification results in different pharmacological properties compared to the parent compound.

Pharmacology

Desmethylsibutramine acts as a serotonin-norepinephrine reuptake inhibitor (SNRI). This means it inhibits the reuptake of the neurotransmitters serotonin and norepinephrine, leading to increased levels of these chemicals in the brain. This mechanism is believed to contribute to its appetite-suppressing effects.

Medical Use

While sibutramine was approved for medical use in the treatment of obesity, desmethylsibutramine itself is not approved as a medication. Sibutramine was withdrawn from the market in many countries due to concerns about its cardiovascular safety profile, including increased risks of heart attack and stroke.

Legal Status

Due to its structural similarity to sibutramine and its potential for similar effects, desmethylsibutramine is often regulated under the same legal frameworks as sibutramine. In many jurisdictions, it is classified as a controlled substance, making its manufacture, distribution, and possession subject to legal restrictions.

Safety and Side Effects

The safety profile of desmethylsibutramine is not well-documented, but it is likely to share similar side effects with sibutramine. These may include increased heart rate, elevated blood pressure, dry mouth, constipation, and insomnia. Due to the potential for serious cardiovascular side effects, the use of desmethylsibutramine is not recommended.

See Also

• Sibutramine
• Appetite suppressant
• Serotonin-norepinephrine reuptake inhibitor
• Obesity